We are live on ! Find out more
WCM

Wildcat Capital Management Portfolio holdings

AUM $229M
1-Year Est. Return 132.65%
This Fund
S&P 500
This Quarter Est. Return
+10.74%
1 Year Est. Return
+132.65%
3 Year Est. Return
+125.67%
5 Year Est. Return
+54.1%
10 Year Est. Return
+1,929.91%
AUM
$131M
AUM Growth
+$9.5M
Cap. Flow
+$35.3M
Cap. Flow %
27.02%
Top 10 Hldgs %
97.42%
Holding
17
New
3
Increased
3
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
URGN icon
UroGen Pharma
URGN
+$4.06M
2
COUP
Coupa Software Incorporated
COUP
+$285K
3
SBR
Sabine Royalty Trust
SBR
+$8.03K

Top Sells

Rank Stock Value
1
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
+$3.09M
2
CSGP icon
CoStar Group
CSGP
+$1.94M

Sector Composition

Rank Sector Weight
1 Real Estate 46.71%
2 Healthcare 19.4%
3 Financials 10.41%
4 Energy 10.38%
5 Communication Services 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSGP icon
1
CoStar Group
CSGP
$11.7B
$61.1M 46.71%
1,479,770
-50,300
-3% -$1.94M
LPLA icon
2
LPL Financial
LPLA
$28.3B
$13.6M 10.41%
208,401
– –
SBR
3
Sabine Royalty Trust
SBR
$1.06B
$13.6M 10.38%
289,963
+173
+0.1% +$8.03K
URGN icon
4
UroGen Pharma
URGN
$1.86B
$12.5M 9.57%
251,459
+69,757
+38% +$4.06M
EDIT icon
5
Editas Medicine
EDIT
$396M
$6.65M 5.09%
185,668
– –
PLAY icon
6
Dave & Buster's
PLAY
$377M
$5.71M 4.37%
120,000
– –
SNNA
7
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$4.49M 3.43%
295,613
– –
APPF icon
8
AppFolio
APPF
$6.38B
$3.51M 2.68%
57,372
– –
PLYA
9
DELISTED
Playa Hotels & Resorts
PLYA
$3.24M 2.48%
300,000
– –
SRNE
10
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$2.99M 2.29%
415,765
– –
IBRX icon
11
ImmunityBio
IBRX
$7.51B
$1.7M 1.3%
556,453
– –
COUP
12
DELISTED
Coupa Software Incorporated
COUP
$999K 0.76%
16,056
+5,352
+50% +$285K
NH
13
DELISTED
NantHealth, Inc
NH
$663K 0.51%
13,358
– –
RDOG icon
14
PUT
ALPS REIT Dividend Dogs ETF
RDOG
$11.4M
$2K ﹤0.01%
+465,000
New +$20.1M
OEF icon
15
CALL
iShares S&P 100 ETF
OEF
$20.1B
$1K ﹤0.01%
+115,200
New +$13.7M
VXX
16
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$1K ﹤0.01%
+55,200
New +$2.13M
VXX
17
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
– –
-80,000
Closed -$3.09M

Similar funds

AFO
Allie Family Office Miami, Florida $228M AUM 17.95% 1-Year Est. Return
CNHF
Conrad N. Hilton Foundation Agoura Hills, California $228M AUM 15.24% 1-Year Est. Return
GCM
GeoSphere Capital Management Miami Beach, Florida $229M AUM 157.16% 1-Year Est. Return
CM
Cosmic Management West Hollywood, California $229M AUM
CSIA
Carl Stuart Investment Advisor Austin, Texas $229M AUM 28.92% 1-Year Est. Return
AF
Abound Financial Granite Bay, California $229M AUM 17.03% 1-Year Est. Return
NIA
NBZ Investment Advisors Knoxville, Tennessee $229M AUM 17.28% 1-Year Est. Return
HFA
Hippocratic Financial Advisors Westlake Village, California $228M AUM 11.95% 1-Year Est. Return

Wildcat Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Wildcat Capital Management held 17 positions worth $131M, up 7.8% from $121M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Wildcat Capital Management deployed $35.3M of net new capital in Q2 2018, opening 3 new positions and adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Real Estate at 47% of assets, up from 46% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CoStar Group, an estimated $1.94M trimmed.

  • Wildcat Capital Management added most to UroGen Pharma in Q2 2018, an estimated $4.06M increase.
  • Wildcat Capital Management's biggest Q2 2018 reduction was CoStar Group, cutting an estimated $1.94M.
  • Wildcat Capital Management fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q2 2018, selling an estimated $3.09M.
  • Wildcat Capital Management's ten largest holdings make up 97% of its $131M portfolio in Q2 2018.
  • Wildcat Capital Management opened 3 new positions and closed 1 in Q2 2018.
  • Wildcat Capital Management's portfolio value rose 7.8% quarter-over-quarter to $131M.

Based on Wildcat Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.